The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BioCardia, Inc(NASDAQ:BCDA) 
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmo...
Website: http://www.biocardia.com/
Full Time Employees: 20
CEO: Peter Altman
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
BioCardia Days Payable Outstanding ttm (DPO)
BioCardia Days Receivable Outstanding ttm (DSO)
BioCardia Op Cashflow Per Share ttm
BioCardia Free Cashflow Per Share ttm
BioCardia Cash Per Share ttm
BioCardia P/S ratio ttm
BioCardia (GAAP) P/E ratio ttm
BioCardia P/B ratio ttm
No extra charts and metrics for this ticker.